Number of Vials of Remdesivir, Tocilizumab and Amphotericin B Supplied for Treatment of COVID-19 Infections by Pharmaceutical Companies Against Allocation Given by Central Government in Delhi
(As on 25.07.2021)
This information is available only to registered Subscriber.
Existing Subscriber please login by providing your and
or IP Access User click for login.